RxDoctor Payments Data

Edward Magee, MD

Family Medicine · Lake Mary, FLNPI 1437107190

Payments from drug & device makers

$805in general payments, 2019–2025

Across 47 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$215
  • Novo Nordisk$95
  • Sanofi-aventis U.S. LLC$83
  • Lilly USA, LLC$66
  • AbbVie$53
  • IBSA Pharma Inc.$51
  • plus $242 from 10 others

What the payments were for

  • Food & beverage$79098%
  • Education$152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$805 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$67,881
Medicare patients
318
Services billed
1,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide94$109,498
EliquisApixaban36$47,615
JardianceEmpagliflozin34$30,229
MounjaroTirzepatide29$29,481
LinzessLinaclotide24$18,989
JanuviaSitagliptin Phosphate13$17,995
Janumet XrSitagliptin Phos/Metformin Hcl17$17,215
SynthroidLevothyroxine Sodium51$4,728
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide118$4,182
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$3,922
Rosuvastatin Calcium368$3,505
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$2,787
Atorvastatin Calcium320$2,351
Levothyroxine Sodium255$2,310
Valsartan101$1,729

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$95$109,49894 claims
PfizerEliquis$26$47,61536 claims
MerckJanuvia, Janumet Xr$39$35,21030 claims
Boehringer IngelheimJardiance$17$30,22934 claims
Lilly USA, LLCMounjaro$66$29,48129 claims
AbbVieLinzess, Synthroid$53$23,71875 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Lake Mary

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →